en
Scientific article
Letter
English

Daclizumab as escape therapy for late acute kidney rejection in the presence of FK506 nephrotoxicity

Published inTransplant international, vol. 13, no. 2, p. 169-171
Publication date2000
Keywords
  • Acute Disease
  • Adult
  • Antibodies, Monoclonal/administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Graft Rejection/prevention & control
  • Humans
  • Immunoglobulin G/administration & dosage
  • Immunosuppressive Agents/administration & dosage/adverse effects
  • Kidney Transplantation
  • Male
  • Tacrolimus/administration & dosage/adverse effects
  • Transplantation, Homologous
Citation (ISO format)
OBERHOLZER, José et al. Daclizumab as escape therapy for late acute kidney rejection in the presence of FK506 nephrotoxicity. In: Transplant international, 2000, vol. 13, n° 2, p. 169–171. doi: 10.1007/s001470050317
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0934-0874
603views
0downloads

Technical informations

Creation04/08/2015 4:03:00 PM
First validation04/08/2015 4:03:00 PM
Update time03/14/2023 11:09:05 PM
Status update03/14/2023 11:09:04 PM
Last indexation01/16/2024 5:39:59 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack